Guo et al. found that miR-20a-5p from exosomes derived from mammary carcinoma cells promoted the proliferative and differentiative abilities of osteoclasts via targeting SRCIN1, offering a reasonable basis for targeting exosomes or miR-20a-5p to intervene in the development of mammary carcinoma [49]. Here, SRCIN1 is linked to breast carcinoma.